CCT-251921

CAS No. 1607837-31-9

CCT-251921 ( CCT 251921;CCT251921 )

Catalog No. M12311 CAS No. 1607837-31-9

A potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 210 Get Quote
10MG 308 Get Quote
25MG 519 Get Quote
50MG 744 Get Quote
100MG 1017 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CCT-251921
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively.
  • Description
    A potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively; reduces STAT1 Ser727 phosphorylation, inhibits tunor growth of APC-mutant SW620 human colorectal carcinoma xenograft mode, has pharmacokinetic, and physicochemical properties.
  • Synonyms
    CCT 251921;CCT251921
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1607837-31-9
  • Formula Weight
    410.91
  • Molecular Formula
    C21H23ClN6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 28 mg/mL. 68.14 mM
  • SMILES
    O=C1NCCC12CCN(C3=C(Cl)C(N)=NC=C3C4=CC5=C(N(C)N=C5)C=C4)CC2
  • Chemical Name
    8-(2-Amino-3-chloro-5-(1-methyl-1H-indazol-5-yl)pyridin-4-yl)-2,8-diazaspiro[4.5]decan-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mallinger A, et al. J Med Chem. 2016 Feb 11;59(3):1078-101.
molnova catalog
related products
  • BUR1

    BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.

  • PF07104091

    PF-07104091 inhibits CDK2, which may lead to cell cycle arrest, induce apoptosis and inhibit tumor cell proliferation.

  • Flavopiridol

    A potent, ATP-competetive CDKs inhibitor with IC50 of 30, 170, 100 nM for CDk1, 2, 4, respectively.